As the first federal opioid trial neared, the pharma industry scrambled to negotiate settlements. The case brought by two Ohio counties was set to be a bellwether for the remaining federal lawsuits. Over two months, nearly every major drug company reached a settlement to avoid the Ohio trial while negotiating larger settlements to resolve 2,500 other federal cases. Read on to see how these negotiations played out.
Please login or register first to view this content.